Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy
- PMID: 1950941
Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy
Abstract
In this study we evaluated, by a standard bactericidal assay, the antibody response to the meningococcal group A and C polysaccharide vaccine used for the immunization programme of the Italian military recruits, compulsory by law since 1987. The percentage of responders, those who developed a four-fold increase in the bactericidal titre to polysaccharide A and C, was 96% and 98%, respectively. No significant side effects were observed after vaccination.
Similar articles
-
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
-
[Humoral immune response to the capsular polysaccharide of Neisseria meningitidis serogroup C in an antimeningococcal BC vaccination trial in Antioquia, Colombia].Bol Oficina Sanit Panam. 1995 Apr;118(4):295-301. Bol Oficina Sanit Panam. 1995. PMID: 7779284 Clinical Trial. Spanish.
-
[Immunity against Neisseria meningitidis in different population groups].Rev Cubana Med Trop. 1989 Jan-Apr;41(1):135-47. Rev Cubana Med Trop. 1989. PMID: 2505344 Spanish.
-
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.Dev Biol Stand. 1998;92:323-33. Dev Biol Stand. 1998. PMID: 9554288 Clinical Trial.
-
Control of meningococcal meningitis with meningococcal vaccines.Yale J Biol Med. 1975 Jul;48(3):197-200. Yale J Biol Med. 1975. PMID: 808913 Free PMC article. Review.